← Back to Clinical Trials
Recruiting NCT06775132

NCT06775132 Associations Between Dietary Intake and Cardiometabolic and Gut Microbiota Outcomes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06775132
Status Recruiting
Phase
Sponsor National University of Singapore
Condition Cardiometabolic Risk Factors
Study Type OBSERVATIONAL
Enrollment 240 participants
Start Date 2025-02-03
Primary Completion 2025-09-30

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age 80 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 240 participants in total. It began in 2025-02-03 with a primary completion date of 2025-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This cross-sectional study aims to investigate the associations between dietary intake, cardiometabolic health markers, and gut microbiota composition in Singapore adults.

Eligibility Criteria

Inclusion Criteria: 1. Able to give informed consent 2. Adults 21-80 years old 3. English-literate 4. Have venous access sufficient to allow for blood sampling as per the protocol 5. No drastic change of diet for the past 1 year 6. If taking medication, has been consistently taking antihypertensive/cholesterol-lowering/type-2 diabetic medication for more than 5 years prior to starting the study. Exclusion Criteria: 1. Taking dietary supplements and fermented foods, which may impact the gut microbiota (e.g. antibiotics, prebiotics, probiotics, yogurt, kimchi) 2 months before starting the 1st study visit only. 2. Taking dietary supplements or medications, which may impact sleep outcomes (e.g. Nutritional Shakes (e.g. Ensure), tryptophan, 5-hydroxytryptophan or melatonin supplementations) 1 month before starting the study. 3. Taking dietary supplements which may impact the eye outcomes (e.g. Vitamin A, vitamin A-containing multivitamin) 2 months before starting the study.

Contact & Investigator

Central Contact

Yao Yueying

✉ yueying.yao@u.nus.edu

📞 +65 83136733

Principal Investigator

Jung Eun Kim

PRINCIPAL INVESTIGATOR

Department of Food Science and Technology, National University of Singapore

Frequently Asked Questions

Who can join the NCT06775132 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, up to 80 Years, studying Cardiometabolic Risk Factors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06775132 currently recruiting?

Yes, NCT06775132 is actively recruiting participants. Contact the research team at yueying.yao@u.nus.edu for enrollment information.

Where is the NCT06775132 trial being conducted?

This trial is being conducted at Singapore, Singapore.

Who is sponsoring the NCT06775132 clinical trial?

NCT06775132 is sponsored by National University of Singapore. The principal investigator is Jung Eun Kim at Department of Food Science and Technology, National University of Singapore. The trial plans to enroll 240 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology